DNA methylation profiling of ovarian carcinomas and their models identifies , , , and as novel targets-5

<p><b>Copyright information:</b></p><p>Taken from "DNA methylation profiling of ovarian carcinomas and their models identifies , , , and as novel targets"</p><p>http://www.molecular-cancer.com/content/6/1/45</p><p>Molecular Cancer 2007;6():45-45.</p><p>Published online 10 Jul 2007</p><p>PMCID:PMC1964763.</p><p></p>dicate the presence of methylated alleles. Panel A illustrates (the upper bands represent MSP products, whereas the lower bands are excess primers). Panel B illustrates . Abbreviation: Pos, positive control (DNA from normal blood is used as control for unmethylated samples, and methylated DNA is used as control for methylated samples); Neg, negative control (template replaced by water); Lane 1–6, individual ovarian carcinomas; 100 bp DNA marker from Promega Corp, Madison, WI, USA. The illustration has been processed from a photo including more samples. Hence, the controls have been moved from their original position and pasted adjacent to the selected samples shown here